Robert John Dorin

Robert John Dorin ( ROBERT JOHN DORIN ) is A Plastic Surgery Physician in New York, NY. The NPI Number for Robert John Dorin is 1134221146.

The current location address for Robert John Dorin is 360 LEXINGTON AVE SUITE 1102 New York, NY 10017 and the contact number is 2128262525 and fax number is 2129805696. The mailing address for Robert John Dorin is 360 LEXINGTON AVE SUITE 1102 New York, NY 10017- 2128262525 (mailing address contact number - 2128262525).

A plastic surgeon deals with the repair, reconstruction or replacement of physical defects of form or function involving the skin, musculoskeletal system, craniomaxillofacial structures, hand, extremities, breast and trunk and external genitalia or cosmetic enhancement of these areas of the body. Cosmetic surgery is an essential component of plastic surgery. The plastic surgeon uses cosmetic surgical principles to both improve overall appearance and to optimize the outcome of reconstructive procedures. The surgeon uses aesthetic surgical principles not only to improve undesirable qualities of normal structures but in all reconstructive procedures as well.

What is the NPI Number for Robert John Dorin ?

Answer: The NPI Number for Robert John Dorin is 1134221146

Where is Robert John Dorin located?

Answer: Robert John Dorin is located at 360 LEXINGTON AVE SUITE 1102 New York, NY 10017.

What is the specialty for Robert John Dorin ?

Answer: The Specialty of Robert John Dorin is A Plastic Surgery Physician.

Are there any online reviews for Robert John Dorin ?

Answer: Yes! Check It Now.

Are there any other health care providers in New York, NY?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Plastic Surgery
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	58
Number of Standardized 30-Day Fills	109.66666667
Aggregate Cost Paid for All Claims	455.11
Number of Day's Supply for All Claims	2833
Number of Medicare Beneficiaries	15
Number of Claims, Including Refills, for Beneficiaries Age 65+	45
Including Refills, for Beneficiaries Age 65+	74.8
Beneficiaries Age 65+	398.09
Number of Day's Supply for All Claims for Beneficaries Age 65+	1827
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	0
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	58
Aggregate Cost Paid for Generic Drugs	455.11
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	22
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	125.22
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	36
Aggregate Cost Paid for Claims Filled by	329.89
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	12
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	83.11
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	46
by Low-Income Subsidy	372
Total Claims of Opioid Drugs, Including
Aggregate Cost Paid for Opioid Drugs
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms
Total Claims of Long-Acting Opioid Drugs
Aggregate Cost Paid for Long-Acting Opioid
Number of Day's Supply of All Long-Acting
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims	0
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	65.666666667
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	0
Number of Male Beneficiaries	15
Number of Non-Hispanic White	15
Number of Black or African American	0
Number of Asian Pacific Islander	0
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not	0
Only Entitlement
Average Hierarchical Condition Category	0.5339333333